To report the fundus findings on multimodal imaging of a membranoproliferative glomerulonephritis type II (MPGNII) patient. A 41-year-old woman had a medical history of renal transplantation for MPGNII 5 years prior to presentation to our clinic for ophthalmic examination. Fundus examination showed macular retinal pigment epithelial changes and large peripapillary atrophy in the right eye, and yellowish bilateral drusen-like deposits peripherally. Fundus fluorescein angiography and indocyanine green angiography revealed multifocal hyperfluorescence in the peripheral retina with accompanying deposits. A hyperautofluorescence pattern was seen in the fundus autofluorescence (FAF) images of the deposits. Spectral domain optical coherence tomography (SD-OCT) scans of the drusen-like material showed retinal pigment epithelium (RPE) elevations with moderate hyperreflectivity underneath. Multiple imaging modalities of the posterior segment can provide detailed information about the ocular involvement of MPGNII and help us to confirm the diagnosis and to follow the lesions.
Introduction
Membranoproliferative glomerulonephritis type II (MPGNII), also known as dense deposit disease, is an inflammation of the glomerulus and one of the major causes of nephrotic syndrome. The main mechanism of the disease is regulation failure of the complement cascade alternative pathway. 1 Electron-dense transformation of the glomerular basement membrane (GBM) is the characteristic histopathological feature of MPGNII. 2 Constitution of dense deposits seen in the renal capillary tuft/GBM/glomerular epithelial interface is analogous to deposits detected in the choroid/ Bruch's membrane/retinal pigment epithelium (RPE) interface. 3 Visual prognosis usually depends on complications secondary to deposit formation. Visual impairment may result from the choroidal neovascular membrane, central serous chorioretinopathy, or macular detachment. 4, 5 Herein, we present the findings of multimodal imaging of the fundus in a patient with MPGNII who had undergone renal transplantation.
Case report
A 41-year-old female patient was admitted to our clinic for routine ophthalmological examination. She had a complaint of vision decrease in her right eye since 10 years. She never had any treatment for her ocular complaints. Past medical history included diagnosis of MPGNII at the age of 15 years. Based on her past medical records, she had undergone renal transplantation for end-stage renal disease 5 years ago and had no evidence of MPGNII recurrence on the transplant tissue, according to the nephrology consultation. On ophthalmic examination, her visual acuity was 20/200 in the right eye and 20/20 in the left eye. Anterior segments were normal bilaterally. Fundus examination showed retinal pigment epithelial changes on the macula, peripapillary atrophic areas extending superiorly and inferiorly in the right eye, and yellow-white, elevated, basal laminar drusen-like lesions peripherally in both eyes ( Fig. 1a and b) . Fundus fluorescein angiography (FFA) showed hyperfluorescence in the macula and peripapillary region in the right eye, superotemporally of the optic disc in the left eye due to a window defect and multiple small, round, well-defined hyperfluorescent spots throughout the peripheral fundus due to staining of drusenlike lesions in both eyes and indocyanine green angiography (ICG-A) revealed small hyperfluorescent areas corresponding to the drusen-like lesions bilaterally (Figs. 2a-l, 3a-f). Fundus autofluorescence (FAF) showed multiple hyperautofluorescent spots in the areas of peripheral deposit lesions in both eyes (Fig. 3g) . Spectral-domain optical coherence tomography (SD-OCT) images of the macula revealed loss of the inner segment/outer segment (IS/OS) of photoreceptors in the right eye (Fig. 4a) , and were normal in the left eye. OCT scans from the deposits showed focal RPE elevations and bumps, with moderate reflectivity below these elevations (Fig. 4b) . Based on clinical examination and imaging, fundus lesions were diagnosed as retinal findings of MPGNII and the patient will continue to follow up in our retina department.
Discussion
Membranoproliferative glomerulonephritis type II is a rare and progressive renal disease that can cause end-stage renal disease. The disease usually presents in the early adulthood and patients often develop drusen-like deposits in the second decade of life, but also visual loss can occur at older ages. 6 Histopathologically, abnormal dense deposits in the Bruch's membrane and choriocapillaris in an MPGNII patient were first reported by Duvall-Young et al. in 1989.
7 D'Souza et al. showed that drusen-like deposits in MPGNII share common compositions with the drusen in age-related macular degeneration (AMD) and suggested that deposits are the end result of both diseases. 3 The alternative complement pathway system components play a critical role in the pathogenesis of MPGNII, and the same factors take part in drusen formation in AMD. 8 Fundus fluorescein angiography and ICG-A have been shown to demonstrate abnormal hyperfluorescent dots, which are possible links to the vascular pathology in the choriocapillaris. 9 Optical coherence tomography scans of the deposits show similar structural features with soft drusen detected in AMD. 10, 11 Scans of the drusen-like lesions show alterations in RPE with elevations accompanying moderate-to-highly reflective material beneath the elevations. In some cases, a hyporeflective image can be seen under the RPE elevations. 11 Drusen, especially soft types, shows increased signals on FAF images because of excessive lipofuscin accumulation. Einbock et al. stated that focal or plaque-like FAF changes in the macula carry a high risk for the progression of geographic atrophy. 12 Our case had large peripapillary atrophic areas extending to the superior and inferior fundus. The possible mechanism may be intense drusen-like deposits around the optic disc causing atrophic changes over time, as seen in AMD.
Visual loss develops due to secondary changes in patients with prolonged fundus findings. Choroidal neovascularization (CNV), central serous chorioretinopathy, and atrophic macula are the main complications that can occur in the course of the disease. 4, 5 Lesions in the fundus can be seen long after renal transplantation with stable renal status. 13 Also, it has been shown that renal transplantation did not affect the development of CNV in 4 patients with long-term follow-up. 13 However, Abazi et al. reported that renal transplantation can provoke the development of retinopathy, including hemorrhages and serous retinal detachment. 14 We did not detect subretinal fluid or choroidal neovascularization in our patient with any of the imaging modalities. In our case, macular and large peripapillary RPE changes and atrophic areas in the right eye might be sequelae of presumed previous serous retinal detachment. However, our patient experienced visual loss in her right eye for 5 years prior to the transplantation and reported no worsening or new complaints after the transplantation.
Histopathological and imaging studies have shown that lesions in AMD and MPGNII share many features in common. However, further investigations with larger groups of patients must be done to differentiate the characteristics between the drusen in AMD and the deposits in MPGNII.
In conclusion, fundus findings may persist for a long time period following renal transplantation. Multimodal imaging may be helpful for the clinicians to diagnose and also to follow the posterior segment changes in patients with MPGNII. In addition, clinicians must be aware of the development of complications secondary to lesions, and periodic ophthalmic examinations must be performed in MPGNII patients.
